Researchers from the Institute of Science Tokyo and Osaka Medical and Pharmaceutical University said that they have developed a peptide that can bind to the spike proteins of SARS-CoV-2 to prevent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback